DP

Dharm Prakash Tripathi

Active Director Director DIN 00844374
DIN 00844374 First appointment Feb 1996 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 4 historical roles
Total affiliations 8 Since Feb 1996
Shareholding value •••• Premium profile

About Dharm Prakash Tripathi

Data last updated:

Dharm Prakash Tripathi is a Director at Credence Remedies Private Limited (since 2024), Director at Gayatri Ai Medi Devices Private Limited (since 2026) and Designated Partner at Gayatri Ai Bio-Resonance Scaalar Llp (since 2024), and holds 1 more current directorship. The companies operate in Pharma, Home Appliances and Life Sciences. The largest current company by reported revenue is Credence Remedies Private Limited at ₹7.41 Cr (FY 2025). Earlier, Dharm Prakash Tripathi was a Director at Sigachi Industries Limited (2014–2018) and Director at Italab Salem Private Limited (2004–2007) and 2 more.

DIN 00844374
Primary Designation Director
Industry Pharma
First Appointment 13 Feb 1996
Oldest Company Age 30 yrs
Largest company Credence Remedies Private Limited · ₹7.41 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Credence Remedies Private Limited U85191MH2011PTC223844
Director22 Apr 20242011₹7.41 Cr (FY 2025)Active
Director24 Jul 20262026Active
Designated Partner12 Aug 20242024Active
Designated Partner09 Jan 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sigachi Industries Limited L24110TG1989PLC009497
Director18 Sep 20141989₹486 Cr (FY 2026)Active
Italab Salem Private Limited U73100TZ2003PTC010442
Director22 Jan 20042003₹1.7 Lakh (FY 2019)Active
Sigachi Cellulos Private Limited U24232TG2007PTC055796
Director24 Jul 20092007Amalgamated
Managing Director13 Feb 19961996Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dpanjali Healthcare Services Llp
Sigachi Cellulos Private Limited
Gayatri Sanks Chem Pharma Private Limied
Gayatri Ai Bio-Resonance Scaalar Llp
Premium access

Shareholding and investment profile for Dharm Prakash Tripathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dharm Prakash Tripathi

Dharm Prakash Tripathi currently holds 4 directorships: Credence Remedies Private Limited (Director, since 22 Apr 2024, revenue ₹7.41 Cr (FY 2025)); Gayatri Ai Medi Devices Private Limited (Director, since 24 Jul 2026); Gayatri Ai Bio-Resonance Scaalar Llp (Designated Partner, since 12 Aug 2024); Dpanjali Healthcare Services Llp (Designated Partner, since 09 Jan 2023).

Dharm Prakash Tripathi was first appointed on 13 Feb 1996 as Managing Director at Gayatri Sanks Chem Pharma Private Limied. The most recent appointment on record is 24 Jul 2026 at Gayatri Ai Medi Devices Private Limited.

Dharm Prakash Tripathi held 4 earlier board appointments: Sigachi Industries Limited (Director, 18 Sep 2014 to 09 Jan 2018); Italab Salem Private Limited (Director, 22 Jan 2004 to 30 Sep 2007); Sigachi Cellulos Private Limited (Director, from 24 Jul 2009); Gayatri Sanks Chem Pharma Private Limied (Managing Director, from 13 Feb 1996).

The current boards of Dharm Prakash Tripathi's companies include Amol Chandrashekar Sule (Credence Remedies Private Limited), Avinash Sitaram Karkhanis (Credence Remedies Private Limited), Dharam Prakash Tripathi (Credence Remedies Private Limited), Pallavi Amol Sule (Credence Remedies Private Limited), Niyati Ashish Shah (Gayatri Ai Medi Devices Private Limited), Priyaranjan Prabhakar Tripathi (Gayatri Ai Medi Devices Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available